← All indications
Herpes Labialis
Herpes simplex, caused by type 1 virus, primarily spread by oral secretions and usually occurring as a concomitant of fever. It may also develop in the absence of fever or prior illness. It commonly involves the facial region, especially the lips and the nares. (Dorland, 27th ed.)
Drugs by status
Approved for this indication (10)
Phase 4 trials (1)
Phase 3 trials (5)
Phase 2 trials (14)
Phase 1 trials (3)
Organizations
Organization Involved with Phase 4 Indications (2)
Organization Involved with Phase 3 Indications (16)
- Meda
- Perrigo
- Medivir
- BlueWillow Biologics
- Valerio
- Integrative Medicine Institute
- Southwest College of Naturopathic Medicine
- University of New Mexico
- Uppsala University
- Icahn School of Medicine at Mount Sinai
- Karolinska Institute
- EMS S/A
- TKL Research
- Medcin Instituto da Pele
- Women's Health Services, Santa Fe, New Mexico
- Matrixx Initiatives, Inc.
Organization Involved with Phase 2 Indications (44)
- AiCuris Anti-infective Cures GmbH
- Beech Tree Labs, Inc.
- Squarex, LLC
- Shulov Innovate for Science Ltd.
- Topical Remedy
- Yung Shin Pharm. Ind. Co., Ltd.
- Derm Research, PLLC
- Transport Pharmaceuticals
- National Institutes of Health (NIH)
- National Institute of Allergy and Infectious Diseases (NIAID)
- Changhua Christian Hospital
- China Academy of Chinese Medical Sciences
- University of Zurich
- University of Utah
- Accelovance
- Novella Clinical
- Wake Research Associates
- Lev Hayasmin Medical center, Natanya
- Hill Top Research
- Westlake Medical Research
- Benchmark Research
- Research Across America
- Advanced Clinical Research Inc.
- J&S Studies Inc.
- Medical Affiliated Research Center, Inc.
- Omega Medical Research
- Coastal Carolina Research
- Front Range Clinical Research
- Bock Clinical Research Incorporated
- Suncoast Clinical Research
- +14 more
Organization Involved with Phase 1 Indications (1)
Organization Involved with Other Experimental Indications (2)